Brain Tumor Clinical Trials Brain Tumor RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas
Conditions:   Glioma, Malignant;   Computer-Assisted Intervention:   Diagnostic Test: Validation of IDH1 mutations from the radiomics model Sponsors:   Mingge LLC;   Huashan Hospital;   Fudan University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Conditions:   Carotid Artery Stenosis;   Glioma;   Intracranial Aneurysm;   Intracranial Hemorrhages;   Brain Tumor Intervention:   Diagnostic Test: biological samples analysis Sponsor:   Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas
Conditions:   Glioma, Malignant;   Computer-Assisted Intervention:   Diagnostic Test: Validation of IDH1 mutations from the radiomics model Sponsors:   Mingge LLC;   Huashan Hospital;   Fudan University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Conditions:   Carotid Artery Stenosis;   Glioma;   Intracranial Aneurysm;   Intracranial Hemorrhages;   Brain Tumor Intervention:   Diagnostic Test: biological samples analysis Sponsor:   Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas
Conditions:   Glioma, Malignant;   Computer-Assisted Intervention:   Diagnostic Test: Validation of IDH1 mutations from the radiomics model Sponsors:   Mingge LLC;   Huashan Hospital;   Fudan University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials